Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
ISSN: 1177-5491
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (505)
- Volume 18, 2024 (9)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Latest articles:
- 5 records -
Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes
Zhou Y, Zhou R, Huang W, Wang J, Jiang C, Li A, Huang CLH, Zhang Y
Biologics: Targets and Therapy 2024, 18:115-127
Published Date: 10 May 2024
Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula
Katsube S, Matsumoto S, Misawa M, Kakizawa N, Hashimoto R, Mizutani T, Matsumoto K, Yoshikawa S, Mashima H
Biologics: Targets and Therapy 2024, 18:107-113
Published Date: 6 May 2024
TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus
Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI
Biologics: Targets and Therapy 2024, 18:95-106
Published Date: 3 May 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Soberanis Pina P, Lheureux S
Biologics: Targets and Therapy 2024, 18:79-93
Published Date: 21 March 2024
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Lin W, Yan Y, Huang Q, Zheng D
Biologics: Targets and Therapy 2024, 18:61-78
Published Date: 31 January 2024